xenoport inc (XNPT:NASDAQ GS)
Executive Profile*
Mark A. Gallop Ph.D.Co-Founder, Xenoport, Inc. |
| Age | Total Calculated Compensation | This person is connected to 26 board members in 2 different organizations across 4 different industries. See Board Relationships |
| 49 | -- |
Background*
Dr. Mark A. Gallop, Ph.D. serves as Scientific Advisor at Protagonist Therapeutics, Inc. Dr. Gallop co-founded Xenoport Inc., in 1999. and served as its Senior Vice President of Research from January 2004 to 2010. Dr. Gallop served as Vice President of Chemistry at Xenoport Inc from 1999 to 2004. He serves as Member of Scientific Advisory Board at Protagonist Pty Ltd. He serves as Member of Scientific Advisory Board at Envoy Therapeutics, Inc. Dr. Gallop held several ...
Corporate Headquarters*3410 Central ExpresswaySanta Clara, California 95051 United States Phone: 408-616-7200 Fax: -- Board Members Memberships*There is no Board Members Memberships data available.Education*PhD University of Cambridge BS The University of Auckland Master's Degree The University of Auckland
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| XNPT:US | $6.75 USD | +0.28 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Michael S. Anderson | Chief Executive Officer and Director Flamel Technologies SA | -- |
| G. Kelly Martin | Chief Executive Officer and Executive Director Elan Corporation, plc | $2.1M |
| James A. Schoeneck | Chief Executive Officer, President and Director DepoMed Inc. | $567.0K |
| Peter Grant | Chief Executive Officer, Chief Financial Officer, Finance Director and Executive Director SkyePharma plc | 245.0K GBP |
| Arun Sawhney B.Com., P.G.D.B.M. | Managing Director, Chief Executive Officer, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee and Member of Science Committee Ranbaxy Laboratories Ltd. | 89.2M | Compensation as of Fiscal Year --. |
Post a JobJobs
- Santa Clara, CA | XenoportPosted: Apr 04
- Santa Clara, CA | XenoportPosted: Feb 22
- Santa Clara, CA | XenoportPosted: Apr 03
- Santa Clara, CA | XenoportPosted: Mar 28
Sponsored Financial Commentaries
Sponsored Links
To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
